Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational Study

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Treatment Sequencing

Real world experience on treatment, outcome and toxicity of crizotinib in patients with anaplastic lymphoma kinase positive advanced non-small cell lung cancer

Journal of Thoracic Disease ◽

10.21037/jtd.2019.09.15 ◽

2019 ◽

Vol 11 (9) ◽

pp. 3864-3873 ◽

Cited By ~ 2

Author(s):

Maria Fatima Flores Del Valle ◽

Alex Yuang-Chi Chang

Keyword(s):

Lung Cancer ◽

Treatment Outcome ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Small Cell Lung ◽

Correction to: Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

Drugs ◽

10.1007/s40265-021-01536-8 ◽

2021 ◽

Author(s):

Diego Kauffmann-Guerrero ◽

Kathrin Kahnert ◽

Rudolf M. Huber

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Treatment Sequencing

EP1.01-03 Real World Outcome of Crizotinib for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer Patients

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2019.08.1975 ◽

2019 ◽

Vol 14 (10) ◽

pp. S911

Author(s):

C. Choi ◽

Y.J. Kim ◽

J.C. Lee ◽

S. Kim ◽

D.H. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cancer Patients ◽

Cell Lung Cancer ◽

Real World ◽

Small Cell ◽

Small Cell Lung ◽

Lung Cancer Patients ◽

P3.01-30 Treatment Sequencing in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) in Japan

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2018.08.1590 ◽

2018 ◽

Vol 13 (10) ◽

pp. S878-S879 ◽

Cited By ~ 1

Author(s):

Y. Goto ◽

N. Yamamoto ◽

E. Masters ◽

H. Kikkawa ◽

J. Mardekian ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Treatment Sequencing ◽

Alk Positive

Treatment Sequencing for Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer

Drugs ◽

10.1007/s40265-020-01445-2 ◽

2020 ◽

Author(s):

Diego Kauffmann-Guerrero ◽

Kathrin Kahnert ◽

Rudolf M. Huber

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Treatment Sequencing

A real‑world study of treatment patterns and survival outcome in advanced anaplastic lymphoma kinase‑positive non‑small‑cell lung cancer

Oncology Letters ◽

10.3892/ol.2018.8444 ◽

2018 ◽

Cited By ~ 2

Author(s):

Ying Jin ◽

Yamei Chen ◽

Xinmin Yu ◽

Xun Shi

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Real World ◽

Treatment Patterns ◽

Survival Outcome ◽

Small Cell ◽

Small Cell Lung ◽

5P Targeted degradation of anaplastic lymphoma kinase by target degraducer in non-small cell lung cancer

Annals of Oncology ◽

10.1016/s0923-7534(21)00167-8 ◽

2016 ◽

Vol 27 ◽

pp. ix2

Author(s):

J.Y. Hwang ◽

C.-H. Park ◽

D.H. Lee ◽

C.H. Kang ◽

C.O. Lee ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Visual Effects in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Crizotinib

Annals of Oncology ◽

10.1016/s0923-7534(20)32041-x ◽

2012 ◽

Vol 23 ◽

pp. xi44

Author(s):

P.-C. Yang ◽

R. Salgia ◽

B. Solomon ◽

A.T. Shaw ◽

D.R. Camidge ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Visual Effects ◽

Anaplastic Lymphoma ◽

Alk Positive ◽

Nsclc Patients

Cost-Effectiveness Analysis Of Ceritinib And Alectinib Versus Crizotinib In The Treatment Of Anaplastic Lymphoma Kinase-Positive Advanced Non-Small Cell Lung Cancer

Cancer Management and Research ◽

10.2147/cmar.s223441 ◽

2019 ◽

Vol Volume 11 ◽

pp. 9195-9202 ◽

Cited By ~ 3

Author(s):

Maobai Liu ◽

Longfeng Zhang ◽

Qishu Huang ◽

Na Li ◽

Bin Zheng ◽

...

Keyword(s):

Lung Cancer ◽

Cost Effectiveness ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Cost Effectiveness Analysis ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Effectiveness Analysis

Favorable response to crizotinib in three patients with echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion-type oncogene-positive non-small cell lung cancer

Cancer Science ◽

10.1111/j.1349-7006.2011.01970.x ◽

2011 ◽

Vol 102 (8) ◽

pp. 1602-1604 ◽

Cited By ~ 9

Author(s):

Takashi Kijima ◽

Kengo Takeuchi ◽

Satoshi Tetsumoto ◽

Kazuki Shimada ◽

Ryo Takahashi ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Anaplastic Lymphoma ◽

Fusion Type